HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management

Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

(2012) Dianne H. Dapito et al.   CANCER CELL

Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies

(2011) Amisha Barochia et al.   Expert Opinion on Drug Metabolism & Toxicology

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

(2011) Tom Luedde et al.   Nature Reviews Gastroenterology & Hepatology

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma

(2010) George P. Kim et al.   INVESTIGATIONAL NEW DRUGS

Lymphotoxins: New Targets for Hepatocellular Carcinoma

(2009) Augusto Villanueva et al.   CANCER CELL

Toll-like receptors as targets in chronic liver diseases

(2009) A Mencin et al.   GUT

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

(2008) Yujin Hoshida et al.   NEW ENGLAND JOURNAL OF MEDICINE